Medically reviewed by Steffini Stalos, DO Hemophilia disease is a rare inherited bleeding disorder. People with this genetic ...

About 30% of people hospitalized due to acquired hemophilia have a bleeding event, while 17% have a blood clot-related ...

The City of College Station issued a proclamation just in time for National Bleeding Disorders Awareness Month.

Treatment involved an antithrombin-based dose regimen targeting antithrombin levels between 15% and 35%, starting at 50 mg ...

This year's Manila Pen Show felt extra special for columnist Alliah Czarielle and her family. It was a lesson on finding ...

The Centers for Disease Control and Prevention (CDC) report that the exact number of people with hemophilia in the United States is unknown, but recent data suggests that as many as 33,000 males ...

This publication examines the clinical and economic impact of hemophilia A, treatment goals, FDA-approved therapies, and managed care factors. People with hemophilia experience lower bone mineral ...

Though research is still ongoing, recent research in gene therapy has led to potentially life-altering treatment for hemophilia B. Other research has improved IX factor products that allow people ...

Hemophilia has loomed large through ... "There's going to be a lot of poor people who can't afford this," McMillan said. Robert Lojewski, a senior vice president and general manager at CSL ...

Jonathan James, CEO, Hope Charities, discusses the critical importance of maintaining access to life-saving medications for ...

Total knee replacement is an operation frequently needed by hemophilia patients, which greatly improves their quality of life. This operation, however, carries a higher risk of bleeding and ...

Dr. Russell Gollard is the Director of Medical Oncology at OptumCare Cancer Care and a Clinical Associate Professor at the University of Nevada, Las Vegas. He has no relevant commercial financial ...